Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT01106495
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT01106495
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01106495. Randomized; single masking; primary purpose treatment. Start 2010-05 (actual); primary completion 2018-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis
- Acronym
- SESA
- Condition
- Atherosclerosis
- Intervention (Device)
- Enhanced External Counterpulsation (EECP)
- Intervention (Drug)
- Simvastatin
- Lead sponsor
- Sun Yat-sen University
Record details
- Record id
cardio:ct-nct01106495- Content hash
2e72bcd0055248b562575152df3a3c3bf849590e8e10e69969ff1a2e6124e756